Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. ($URGN), sold shares on the open market eight times over the last year, totaling about $725,000. His most recent sale occurred on February 3, 2026. These transactions rank him 5,656th among 11,678 insiders in our database by sale value, below the average of $8.6 million per seller and 6.4 transactions. Schoenberg made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1844 | $19.69 | 150,514.0000 | 48,057,386 | 1.21% | 0.00% |
| Feb. 3, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1843 | $19.69 | 148,671.0000 | 48,057,386 | 1.22% | 0.00% |
| Feb. 3, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 3686 | $19.69 | 144,985.0000 | 48,057,386 | 2.48% | 0.01% |
| Jan. 31, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3334 | $0.00 | 0.0000 | 48,057,386 | 100.00% | 0.01% |
| Jan. 31, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 6666 | $0.00 | 13,334.0000 | 48,057,386 | 33.33% | 0.01% |
| Jan. 31, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3333 | $0.00 | 3,334.0000 | 48,057,386 | 49.99% | 0.01% |
| Jan. 31, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3333 | $0.00 | 145,692.0000 | 48,057,386 | 2.34% | 0.01% |
| Jan. 31, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 6666 | $0.00 | 152,358.0000 | 48,057,386 | 4.58% | 0.01% |
| Jan. 31, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3334 | $0.00 | 142,359.0000 | 48,057,386 | 2.40% | 0.01% |
| Jan. 31, 2026 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | A | Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 48,057,386 | 9999.99% | 0.04% |
| Nov. 19, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 10000 | $25.00 | 139,025.0000 | 48,057,386 | 6.71% | 0.02% |
| Sept. 7, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 1667 | $0.00 | 149,896.0000 | 47,030,820 | 1.12% | 0.00% |
| Sept. 7, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 1667 | $0.00 | 1,667.0000 | 47,030,820 | 50.00% | 0.00% |
| Sept. 8, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 871 | $19.11 | 149,025.0000 | 47,030,820 | 0.58% | 0.00% |
| Aug. 11, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 10000 | $17.69 | 148,229.0000 | 47,030,820 | 6.32% | 0.02% |
| July 28, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 5149 | $19.14 | 158,229.0000 | 47,030,820 | 3.15% | 0.01% |
| July 28, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 10000 | $0.00 | 163,378.0000 | 47,030,820 | 6.52% | 0.02% |
| June 9, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 5162 | $7.37 | 153,378.0000 | 47,030,820 | 3.26% | 0.01% |
| June 8, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 10000 | $0.00 | 158,540.0000 | 47,030,820 | 6.73% | 0.02% |
| June 8, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 10000 | $0.00 | 10,000.0000 | 47,030,820 | 50.00% | 0.02% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 1334 | $0.00 | 0.0000 | 47,030,820 | 100.00% | 0.00% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 1334 | $0.00 | 146,425.0000 | 47,030,820 | 0.92% | 0.00% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 759 | $11.14 | 145,666.0000 | 47,030,820 | 0.52% | 0.00% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3333 | $0.00 | 148,999.0000 | 47,030,820 | 2.29% | 0.01% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1896 | $11.14 | 147,103.0000 | 47,030,820 | 1.27% | 0.00% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3333 | $0.00 | 150,436.0000 | 47,030,820 | 2.27% | 0.01% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1896 | $11.14 | 148,540.0000 | 47,030,820 | 1.26% | 0.00% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3333 | $0.00 | 3,334.0000 | 47,030,820 | 49.99% | 0.01% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3333 | $0.00 | 6,667.0000 | 47,030,820 | 33.33% | 0.01% |
| Jan. 31, 2025 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | A | Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 47,030,820 | 9999.99% | 0.04% |
| Sept. 9, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 1666 | $0.00 | 3,334.0000 | 40,501,315 | 33.32% | 0.00% |
| Sept. 9, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 859 | $13.08 | 145,091.0000 | 40,501,315 | 0.59% | 0.00% |
| Sept. 9, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 1666 | $0.00 | 145,950.0000 | 40,501,315 | 1.15% | 0.00% |
| June 10, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 10000 | $0.00 | 20,000.0000 | 37,059,186 | 33.33% | 0.03% |
| June 10, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 5153 | $13.08 | 144,284.0000 | 37,059,186 | 3.45% | 0.01% |
| June 10, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 10000 | $0.00 | 149,437.0000 | 37,059,186 | 7.17% | 0.03% |
| March 18, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 12000 | $14.05 | 139,437.0000 | 36,153,634 | 7.92% | 0.03% |
| Feb. 1, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1137 | $15.78 | 149,423.0000 | 36,153,634 | 0.76% | 0.00% |
| Feb. 1, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 758 | $15.78 | 149,998.0000 | 36,153,634 | 0.50% | 0.00% |
| Feb. 1, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1894 | $15.78 | 151,437.0000 | 36,153,634 | 1.24% | 0.01% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | A | Restricted Stock Units | 10000 | $0.00 | 10,000.0000 | 36,153,634 | 9999.99% | 0.03% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 2000 | $0.00 | 150,560.0000 | 36,153,634 | 1.35% | 0.01% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1137 | $15.74 | 149,423.0000 | 36,153,634 | 0.76% | 0.00% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 1333 | $0.00 | 150,756.0000 | 36,153,634 | 0.89% | 0.00% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 758 | $15.74 | 149,998.0000 | 36,153,634 | 0.50% | 0.00% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Ordinary Shares | 3333 | $0.00 | 153,331.0000 | 36,153,634 | 2.22% | 0.01% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | S | Ordinary Shares | 1894 | $15.74 | 151,437.0000 | 36,153,634 | 1.24% | 0.01% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 2000 | $0.00 | 0.0000 | 36,153,634 | 100.00% | 0.01% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 1333 | $0.00 | 1,334.0000 | 36,153,634 | 49.98% | 0.00% |
| Jan. 31, 2024 | UroGen Pharma Ltd. | $URGN | Schoenberg Mark | Chief Medical Officer | M | Restricted Stock Units | 3333 | $0.00 | 6,667.0000 | 36,153,634 | 33.33% | 0.01% |